Clinical trials referenced in this document:
Documents that mention this clinical trial
Impairments in brain perfusion, executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic Moyamoya disease
Received: 23 January 2021
Accepted: 19 April 2021
First Online: 12 May 2021
: The study was approved by the institutional review committee of Beijing Tiantan Hospital, Capital Medical University (KYSQ2019-058–01) and was performed in accordance with the principles expressed in the Declaration of Helsinki. All study participants provided written informed consent.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.